Item 9 Labs (OTC:INLB) Shares Down 5.7%
Item 9 Labs (OTC:INLB) Shares Down 5.7%
Item 9 Labs Corp. (OTC:INLB – Get Rating)'s share price fell 5.7% on Tuesday . The company traded as low as $0.25 and last traded at $0.25. 33,714 shares traded hands during trading, an increase of 73% from the average session volume of 19,515 shares. The stock had previously closed at $0.27.
Item 9 Labs Stock Down 5.7 %
The firm has a market cap of $24.42 million, a P/E ratio of -1.00 and a beta of 0.33. The business's fifty day moving average price is $0.30 and its two-hundred day moving average price is $0.53. The company has a current ratio of 0.14, a quick ratio of 0.04 and a debt-to-equity ratio of 0.02.
Item 9 Labs Company Profile
(Get Rating)
Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona.
See Also
- Get a free copy of the StockNews.com research report on Item 9 Labs (INLB)
- We Are the Champions: 3 Dividend Growers Wall Street Loves
- Will Nordstrom Stock be the Grinch This Year?
- Harpoon Therapeutics Remains Volatile After Promising News
- What is Market Structure in Trading?
- Institutional Selling Is No Headwind For Nike
Receive News & Ratings for Item 9 Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Item 9 Labs and related companies with MarketBeat.com's FREE daily email newsletter.
Item 9 Labs Corp. (OTC:INLB – Get Rating)'s share price fell 5.7% on Tuesday . The company traded as low as $0.25 and last traded at $0.25. 33,714 shares traded hands during trading, an increase of 73% from the average session volume of 19,515 shares. The stock had previously closed at $0.27.
Item 9 Labs Corp.(場外交易代碼：INLB-GET Rating)的股價週二下跌5.7%。該公司股價一度跌至0.25美元，最新報0.25美元。33,714股股票在交易中成交，較19,515股的平均成交量增加了73%。該股此前收盤報0.27美元。
Item 9 Labs Stock Down 5.7 %
第9項實驗室庫存下降5.7%
The firm has a market cap of $24.42 million, a P/E ratio of -1.00 and a beta of 0.33. The business's fifty day moving average price is $0.30 and its two-hundred day moving average price is $0.53. The company has a current ratio of 0.14, a quick ratio of 0.04 and a debt-to-equity ratio of 0.02.
該公司市值為2442萬美元，本益比為-1.00，貝塔係數為0.33。該業務的50日移動均線價格為0.30美元，200日移動均線價格為0.53美元。該公司的流動比率為0.14，速動比率為0.04，債務權益比率為0.02。
Item 9 Labs Company Profile
第9項實驗室公司簡介
(Get Rating)
(獲取評級)
Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona.
第九項實驗室公司在美國是一家垂直整合的大麻運營商和藥房特許經營商。該公司生產各種類別的大麻和大麻相關產品，如鮮花、濃縮物、蒸餾液和五金製品。它通過獲得許可的藥房向亞利桑那州的消費者提供大麻和大麻衍生產品和技術。
See Also
另請參閱
- Get a free copy of the StockNews.com research report on Item 9 Labs (INLB)
- We Are the Champions: 3 Dividend Growers Wall Street Loves
- Will Nordstrom Stock be the Grinch This Year?
- Harpoon Therapeutics Remains Volatile After Promising News
- What is Market Structure in Trading?
- Institutional Selling Is No Headwind For Nike
- 免費獲取StockNews.com關於第9項實驗室的研究報告(INLB)
- 我們是冠軍：華爾街鍾愛的3位股息種植者
- 諾德斯特龍股票公司會成為今年的格林奇嗎？
- 魚叉治療公司在有希望的消息傳出後仍不穩定
- 交易中的市場結構是什麼？
- 機構銷售對耐克來說不是逆風
Receive News & Ratings for Item 9 Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Item 9 Labs and related companies with MarketBeat.com's FREE daily email newsletter.
每天接收第九項實驗的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收關於Item 9實驗室和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧